Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/19/18
End: 03/16/20
Due: 03/16/21
Phase: N/A
Priority: Normal
Start: 03/04/21
End: 02/06/23
Due: 02/06/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of Parenterally-administered Teverelix TFA in Healthy Male Volunteers | NCT03781947 | Antev Ltd. | user2@example.com | None | 2018-11-19 | 2020-03-16 | 2021-03-16 | - | - | 2025-07-14 |
| Teverelix Evaluated in Advanced Prostate Cancer | NCT04693507 | Antev Ltd. | user2@example.com | None | 2021-03-04 | 2023-02-06 | 2024-02-06 | - | - | 2025-07-14 |